The Future of Bioprinting with Cellink CEO Erik Gatenholm

This week, we are joined by Erik Gatenholm, the Co-founder and CEO of Cellink. Cellink is a bio-convergence startup focused on bioprinting. The company's services provide critical breakthroughs in cell culturing, tissue engineering & drug development. Stayed tuned after the amazing interview to hear Brett and Ryan discuss their favorite stories from the week. Let's go! 7investing is empowering members to invest in their future. Use our code “CCM” to get $10 off your first month or annual subscription, or use this link: https://7investing.com/subscribe/ Want more of Erik Gattenholm? Follow him on Twitter: https://twitter.com/egatenholm?s=20 Want updates on future shows and projects? Follow us on Twitter: https://twitter.com/chitchatmoney Rather watch us on video? Subscribe to our YouTube channel: https://www.youtube.com/channel/UCG5Ni-SI-jyrEsoNUhqftNQ Contact us: [email protected] Timestamps Interview | (3:29) Interview Continued | (25:45) Show Notes | (43:30) Disclosure: Chit Chat Money hosts and guests are not financial advisors, and nothing they say on this show is formal advice or a recommendation. Brett Schafer and Ryan Henderson are general partners and portfolio managers at Arch Capital. Arch Capital and its partners may hold securities discussed on this show. Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices